ARM is the leading international advocacy organization championing the benefits of engineered cell therapies and genetic medicines for patients, healthcare systems, and society. We unite industry, patients, and partners to unlock their potential.
As a community, ARM builds the future of medicine by convening the sector, facilitating influential exchanges on policies and practices, and advancing the field with data and analysis.
ARM envisions a world where cell and gene therapies are fully integrated into healthcare systems worldwide, healing patients, restoring function, and transforming lives.
Charting the Future of CGT
Since our founding, ARM has played a central role in advancing regenerative medicine, from key advocacy wins to global expansion. Explore the milestones that have shaped our work and the field.
ARM was founded to bring together diverse stakeholders across science, industry, and policy. From day one, ARM has worked to accelerate access to transformative therapies by aligning the CGT community around shared goals and advocacy priorities.
ARM launched a European chapter—the Alliance for Advanced Therapeutics—and reached 100 members. Though later reabsorbed, this laid the foundation for ARM’s permanent presence in Brussels and global advocacy efforts.
ARM hosted the inaugural Cell & Gene Meeting on the Mesa in California. Now held annually in Phoenix, it draws 2,000+ global biotech leaders to explore the latest in CGT science, strategy, and commercialization.
To connect Europe’s CGT ecosystem, ARM launched the Cell & Gene Meeting on the Med. Held each spring in Rome, it continues to unite regional innovators, investors, and policymakers advancing regenerative medicine.
Leadership united by a shared vision for CGT.
Join a collaborative, mission-driven team with a shared commitment to advancing cell and gene therapies.
